Get the Stockscreener App
1.54
2.53%
-0.04
Pre-market:
1.55
0.01
+0.65%
Calidi Biotherapeutics Inc stock is traded at $1.54, with a volume of 47,027.
It is down -2.53% in the last 24 hours and up +1.32% over the past month.
Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.
See More
Previous Close:
$1.58
Open:
$1.59
24h Volume:
47,027
Relative Volume:
0.19
Market Cap:
$8.45M
Revenue:
-
Net Income/Loss:
$-23.36M
P/E Ratio:
-2.0901
EPS:
-0.7368
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+1.32%
6M Performance:
-73.40%
1Y Performance:
-89.12%
1-Day Range:
$1.5001
$1.59
1-Week Range:
$1.46
$1.6899
52-Week Range:
$1.41
$46.68
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
Name
Calidi Biotherapeutics Inc
Sector
Industry
Phone
(858) 794-9600
Address
4475 Executive Drive, Suite 200, San Diego
Compare CLDI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.54 | 8.45M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-23 | Initiated | H.C. Wainwright | Buy |
| Oct-09-23 | Initiated | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Multi asset correlation models including Calidi Biotherapeutics Inc.2025 Year in Review & Weekly Watchlist for Consistent Profits - newser.com
Calidi Biotherapeutics Inc. stock trendline breakdown2025 Analyst Calls & Weekly High Return Forecasts - newser.com
What earnings margins imply for Calidi Biotherapeutics Inc. stockWeekly Investment Summary & Real-Time Buy Zone Alerts - newser.com
Will Calidi Biotherapeutics Inc. stock see insider buyingTrade Risk Report & Risk Controlled Daily Plans - newser.com
Can Calidi Biotherapeutics Inc. stock rebound after recent weaknessPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Will Calidi Biotherapeutics Inc. benefit from macro trendsJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Can Calidi Biotherapeutics Inc. stock beat market expectations this quarterTrade Risk Assessment & Capital Efficiency Focused Ideas - newser.com
Full technical analysis of Calidi Biotherapeutics Inc. stockGap Up & High Yield Stock Recommendations - newser.com
Calidi Biotherapeutics Sells Majority Stake in Nova Cell - TipRanks
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsJuly 2025 Action & Target Return Focused Picks - newser.com
Using data models to predict Calidi Biotherapeutics Inc. stock movementJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Key resistance and support levels for Calidi Biotherapeutics Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Calidi Biotherapeutics Inc.’s volatility index tracking explainedQuarterly Growth Report & Technical Buy Zone Confirmations - newser.com
What momentum shifts mean for Calidi Biotherapeutics Inc.Insider Buying & Technical Entry and Exit Tips - newser.com
Calidi Biotherapeutics (CLDI) Stock Trends and Sentiment 2025 - MarketBeat
Calidi announces new data to be presented on CLD-401 at 2025 SITC meeting - TipRanks
CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan
Calidi (NYSE American: CLDI) to Present CLD-401 at SITC; IND Submission Targeted for 2026 - Stock Titan
Using RSI to spot recovery in Calidi Biotherapeutics Inc.July 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Can Calidi Biotherapeutics Inc. stock surprise with earnings upsideWeekly Investment Recap & Real-Time Buy Signal Alerts - Fundação Cultural do Pará
How Calidi Biotherapeutics Inc. stock reacts to stronger dollarWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Calidi Biotherapeutics Inc Stock (CLDI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Cap:
|
Volume (24h):